Key Highlights
- The cybersecurity firm increased its stock repurchase authorization by $500M, reaching a total of $1.5 billion.
- Shares began Monday trading at $399.12 with the company valued at approximately $101.2 billion.
- Morgan Stanley elevated its rating to Overweight with a $510 price objective; consensus target reaches ~$505.
- Institutional ownership represents 71.16% of outstanding shares; company executives divested roughly 68,636 shares valued at $28.7M during the previous quarter.
- Fourth-quarter revenue totaled $1.31B, representing a 23.8% annual increase and surpassing projections by approximately $10M.
Shares of CrowdStrike (CRWD) commenced Monday’s session at $399.12, significantly below the 52-week peak of $566.90.
CrowdStrike Holdings, Inc., CRWD
The cloud-native security platform provider revealed Monday that it has boosted its share repurchase initiative by $500 million, elevating the complete authorization to $1.5 billion. Under the previous program, the organization has already acquired 413,130 Class A common shares at an average cost of $364.57, representing a cumulative expenditure of $150.6 million.
Chief Financial Officer Burt Podbere connected the decision to the firm’s extended-term objective of achieving $20 billion in annual recurring revenue by fiscal 2036. “We have increased our share repurchase authorization to $1.5 billion to opportunistically return value to shareholders,” Podbere stated.
The buyback expansion arrives while CRWD trades approximately 30% beneath its 52-week high, a decline partially attributed to sector-wide pressure following worries that emerging AI capabilities might displace certain security operations.
The equity’s 50-day moving average rests at $411.92, while the 200-day moving average stands at $467.32 — both positioned above current trading levels.
Wall Street Maintains Favorable Outlook
Street coverage continues to lean positive. Morgan Stanley elevated CRWD from equal weight to overweight during March, pushing its price objective from $487 to $510. Truist maintains a buy recommendation with a $550 forecast, while Daiwa holds an outperform stance with a $500 projection. The consensus analyst price objective registers at approximately $504.98, with a “Moderate Buy” rating across 51 covering analysts.
Coverage breaks down to one strong buy, 34 buy recommendations, 15 hold ratings, and a single sell designation.
Runnymede Capital Advisors established a fresh position during Q4, acquiring 3,160 shares valued at approximately $1.48 million. Multiple other institutional participants expanded their stakes during recent periods, including Carnegie Investment Counsel and Traynor Capital Management.
Zacks Research moved CRWD from strong sell to hold during March, coinciding with the company’s fourth-quarter performance that exceeded earnings projections — delivering $1.12 EPS compared to the $1.10 consensus, alongside revenue of $1.31 billion versus the anticipated $1.30 billion.
Executive Divestment Activity Persists
Meanwhile, company leadership has maintained a pattern of share sales. Chief Executive George Kurtz divested 28,853 shares during early February at an average price of $413.01, generating approximately $11.9 million. This transaction decreased his stake by 1.38%, leaving him with roughly 2.05 million shares.
President Michael Sentonas sold 19,367 shares in late March at $411.06, amounting to about $7.96 million. Collectively, company insiders have divested approximately 68,636 shares valued at $28.7 million throughout the past 90 days. Executive ownership currently represents about 3.32% of the organization.
CrowdStrike has also recently enhanced its GovCloud platform and introduced a CTEM service in partnership with HCLTech, both initiatives designed to expand its presence across enterprise and government sectors.
The security software provider operates within a 52-week range spanning from $298.00 to $566.90. Wall Street projects EPS of $0.55 for the ongoing fiscal year.
